We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$19.9B
AUM Growth
+$1.62B
Cap. Flow
-$35.6M
Cap. Flow %
-0.18%
Top 10 Hldgs %
43.73%
Holding
208
New
17
Increased
41
Reduced
35
Closed
35

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$384M
2
VMW
VMware, Inc
VMW
+$286M
3
UNH icon
UnitedHealth
UNH
+$192M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$158M
5
IQV icon
IQVIA
IQV
+$132M

Top Sells

Rank Stock Value
1
SJR
Shaw Communications Inc.
SJR
+$473M
2
DT icon
Dynatrace
DT
+$329M
3
CRM icon
Salesforce
CRM
+$318M
4
MSFT icon
Microsoft
MSFT
+$253M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$191M

Sector Composition

Rank Sector Weight
1 Healthcare 35.32%
2 Technology 16.45%
3 Financials 12.17%
4 Industrials 7.23%
5 Communication Services 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIMO icon
51
Silicon Motion
SIMO
$8.76B
$67.2M 0.34%
935,000
+230,000
+33% +$14.7M
OPCH icon
52
Option Care Health
OPCH
$3.55B
$67.2M 0.34%
+2,067,134
New +$62.3M
NTRA icon
53
Natera
NTRA
$47.9B
$64.4M 0.32%
1,324,183
+662,400
+100% +$33.8M
ARGX icon
54
argenx
ARGX
$65B
$62.7M 0.31%
+161,000
New +$63.3M
THC icon
55
Tenet Healthcare
THC
$22.6B
$61.2M 0.31%
752,000
+363,000
+93% +$25.8M
CI icon
56
Cigna
CI
$73.3B
$61.2M 0.31%
+218,000
New +$56.8M
MASI
57
DELISTED
Masimo
MASI
$60.5M 0.3%
367,649
-264,000
-42% -$46M
KDNY
58
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$58.5M 0.29%
+1,523,000
New +$39.1M
EVH icon
59
Evolent Health
EVH
$536M
$57.6M 0.29%
1,900,909
+757,000
+66% +$24.5M
EXAS
60
DELISTED
Exact Sciences
EXAS
$56.5M 0.28%
+602,000
New +$47M
AJRD
61
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$52.6M 0.26%
959,378
+689,378
+255% +$38.3M
RETA
62
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$46.1M 0.23%
451,700
+126,700
+39% +$12M
TSEM icon
63
Tower Semiconductor
TSEM
$25.2B
$43.5M 0.22%
1,160,000
+185,000
+19% +$7.65M
UTHR icon
64
United Therapeutics
UTHR
$22B
$42.7M 0.21%
193,267
-471,500
-71% -$104M
ENTA icon
65
Enanta Pharmaceuticals
ENTA
$392M
$40.1M 0.2%
1,875,000
+325,000
+21% +$9.58M
AMAM
66
DELISTED
Ambrx Biopharma Inc
AMAM
$37.3M 0.19%
2,269,000
+1,908,000
+529% +$24M
SVRA icon
67
Savara
SVRA
$1.15B
$34.9M 0.17%
10,908,086
– –
LU icon
68
Lufax Holding
LU
$1.2B
$28.5M 0.14%
4,987,455
-4,586,681
-48% -$30.3M
ROIV icon
69
Roivant Sciences
ROIV
$26.2B
$23.7M 0.12%
+2,355,000
New +$21.1M
AEL
70
DELISTED
American Equity Investment Life Holding Company
AEL
$20M 0.1%
+383,000
New +$15.4M
AXSM icon
71
Axsome Therapeutics
AXSM
$10.9B
$19.6M 0.1%
+272,800
New +$20.1M
SEDA
72
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$18.1M 0.09%
1,732,500
– –
BHVN icon
73
Biohaven
BHVN
$2.09B
$17.9M 0.09%
750,000
– –
ZYME icon
74
Zymeworks
ZYME
$2.05B
$17.3M 0.09%
2,000,000
– –
AAC
75
DELISTED
Ares Acquisition Corporation
AAC
$15.1M 0.08%
1,425,000
– –
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2023 Portfolio in Review

As of Q2 2023, Thomas Steyer held 208 positions worth $19.9B, up 8.8% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Thomas Steyer's Q2 2023 filing shows 17 new, 41 increased, 35 reduced and 35 closed positions. Its largest new stake was Analog Devices: 2,075,000 shares worth $404M. The largest sale was Shaw Communications Inc., an estimated $473M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q2 2023 buy was Analog Devices: 2,075,000 shares worth $404M.
  • Thomas Steyer added most to VMware, Inc in Q2 2023, an estimated $286M increase.
  • Thomas Steyer's biggest Q2 2023 reduction was Salesforce, cutting an estimated $318M.
  • Thomas Steyer fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $473M.
  • Thomas Steyer's ten largest holdings make up 44% of its $19.9B portfolio in Q2 2023.
  • Thomas Steyer opened 17 new positions and closed 35 in Q2 2023.
  • Thomas Steyer's portfolio value rose 8.8% quarter-over-quarter to $19.9B.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.